Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze FOLD stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate FOLD investment potential.

What is FOLD stock price today?

Get real-time FOLD stock price, historical data, and price charts on Financhill. Track FOLD performance with our advanced analysis tools.

Is FOLD a good investment?

Evaluate FOLD investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy FOLD stock?

To buy FOLD stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of FOLD?

View detailed market capitalization data and company valuation metrics for FOLD on our comprehensive analysis page.

What is the P/E ratio of FOLD?

Use our fundamental analysis tools to view FOLD P/E ratio and compare valuation metrics with industry peers.

What are FOLD earnings?

View FOLD earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Amicus Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Buy

FOLD
Amicus Therapeutics, Inc.

Last Price:

$14.35

Seasonality Move:

-5.3%

7 Day Trial

ALL ACCESS PASS

$ 7

Amicus Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 17.6% based on the past 18 years of stock performance.
Amicus Therapeutics, Inc. has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Is Amicus Therapeutics, Inc. Stock Undervalued?

The current Amicus Therapeutics, Inc. [FOLD] share price is $14.35. The Score for FOLD is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
FOLD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Amicus Therapeutics, Inc. has on average historically risen by 17.6% based on the past 18 years of stock performance.

Amicus Therapeutics, Inc. Stock Rating

Buy

Amicus Therapeutics, Inc. (FOLD) is a Buy

Is Amicus Therapeutics, Inc. overpriced?

Amicus Therapeutics, Inc. has risen higher in 8 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%

Amicus Therapeutics, Inc. Stock Price History

Is FOLD stock going to rise?

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

amicusrx.com

52-Week Data

52-Week High:

14.38

52-Week Low:

5.51

Prediction Charts

Market Cap:

4.5B

Price in USD:

14.35

Volume:

3.4M

Beta:

0.97

Technical Analysis

SMA50:

13.59

SMA100:

11.25

SMA200:

8.96

52-Wk Change:

50.1%

Stock Predictions

Is Amicus Therapeutics, Inc. stock public?

Yes, Amicus Therapeutics, Inc. is a publicly traded company.
What is the Amicus Therapeutics, Inc. stock quote today?

The Amicus Therapeutics, Inc. stock price is 14.35 USD today.
How to buy Amicus Therapeutics, Inc. stock online?

You can buy Amicus Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Jan-30	14.27	14.29	14.29	14.27
Feb-2	14.29	14.29	14.30	14.28
Feb-3	14.29	14.28	14.30	14.27
Feb-4	14.28	14.27	14.30	14.26
Feb-5	14.27	14.28	14.29	14.26
Feb-6	14.30	14.30	14.30	14.26
Feb-9	14.30	14.30	14.30	14.28
Feb-10	14.31	14.30	14.32	14.29
Feb-11	14.32	14.31	14.36	14.30
Feb-12	14.33	14.33	14.35	14.30
Feb-13	14.35	14.31	14.35	14.30
Feb-17	14.31	14.30	14.35	14.30
Feb-18	14.32	14.34	14.35	14.31
Feb-19	14.34	14.35	14.35	14.34

Amicus Therapeutics, Inc. Earnings

Amicus Therapeutics, Inc. Earnings Report: Per Share Amicus Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics, Inc. Forecast Revenue Growth

Amicus Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.27 per share.

* Amicus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.